Komori
The Yamagata Bank (8344) · FactMitigated

Quarterly Comprehensive Income Deficit Due to a Decrease in Valuation Differences on Other Securities

First written in FY2019-Q3. 14 of 23 entries say "Mitigated", first in FY2020-Q1. Latest entry: 2026-08-03.

23entries
8years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMitigatedFY2021-Q1 – FY2021WorsenedFY2022-Q3 – FY2023MitigatedFY2024-Q1 – 2026-08-032019: 420192020: 420202021: 220212022: 420222023: 420232024: 320242025: 120252026: 12026
Same theme, other companies
Changes in Net Assets, Valuation Differences, etc.A theme 68 companies write about · 33 as a headwind · 26 as a tailwind

The whole theme swung hardest in 2022: 10 of 55 companies on the "Worse" side.

8 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 68 companies compared. The sentences above are computed from all 68.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-03MitigatedEarnings

    「Valuation gains and losses on other securities increased by ¥12.7 billion year on year to a valuation loss of ¥8.3 billion, as the increase in valuation gains and losses on equities and other securities outweighed the decline in valuation gains and losses on bonds.」

    The valuation loss on other securities narrowed from ¥21.1 billion in the same period of the previous year to ¥8.3 billion, and quarterly comprehensive income remained positive.
  2. FY2026-H1MitigatedAnnual report

    「Other comprehensive income: (2,851), 12,865 Valuation difference on available-for-sale securities: (2,661), 11,570 Comprehensive income for the interim period: (763), 15,577」

    The valuation difference on available-for-sale securities changed from a loss of ¥2,661 million in the same period of the previous year to a gain of ¥11,570 million, while comprehensive income for the interim period improved from a loss of ¥763 million to a gain of ¥15,577 million.
  3. FY2025-H1MitigatedAnnual report

    「Other comprehensive income: (3,307), (2,851); valuation difference on available-for-sale securities: (3,386), (2,661); comprehensive income for the interim period: (1,744), (763)」

    The loss on the valuation difference on available-for-sale securities narrowed from ¥3,386 million in the same period of the previous year to ¥2,661 million, while the loss in comprehensive income for the interim period narrowed from ¥1,744 million to ¥763 million.
  4. FY2024MitigatedAnnual report

    「Valuation difference on available-for-sale securities: (24,465), 7,583; comprehensive income: (20,713), 11,201」

    The valuation difference on available-for-sale securities changed from a loss of ¥24,465 million to a gain of ¥7,583 million, while comprehensive income also improved from a loss of ¥20,713 million to a gain of ¥11,201 million.
  5. FY2024-Q3MitigatedAnnual report

    「Other comprehensive income (28,868) 4,039 Valuation difference on available-for-sale securities (29,377) 4,013 Deferred gains or losses on hedges 624 147 Remeasurements of defined benefit plans (115) (120) Comprehensive income for the quarter (25,664) 6,160」

    The valuation difference on available-for-sale securities changed from a loss of ¥29,377 million in the same period of the previous year to a gain of ¥4,013 million, while comprehensive income for the quarter improved from a loss of ¥25,664 million to a gain of ¥6,160 million.
  6. FY2024-Q2MitigatedAnnual report

    「Other comprehensive income (24,652) (3,307) Valuation difference on available-for-sale securities (25,034) (3,386) Comprehensive income for the interim period (21,190) (1,744)」

    The loss on the valuation difference on available-for-sale securities narrowed from ¥25,034 million in the same period of the previous year to ¥3,386 million, while the loss in comprehensive income for the interim period narrowed from ¥21,190 million to ¥1,744 million.
  7. FY2024-Q1MitigatedAnnual report

    「Other comprehensive income: (16,308), 4,438; valuation difference on available-for-sale securities: (16,898), 4,484; comprehensive income for the quarter: (15,382), 4,644」

    The valuation difference on available-for-sale securities changed from a loss of ¥16,898 million in the same period of the previous year to a gain of ¥4,484 million, while comprehensive income for the quarter improved from a loss of ¥15,382 million to a gain of ¥4,644 million.
  8. FY2023WorsenedAnnual report

    「Valuation difference on available-for-sale securities: (24,465); comprehensive income: (20,713)」

    The loss on the valuation difference on available-for-sale securities widened from ¥8,753 million to ¥24,465 million, while the loss in comprehensive income also widened from ¥4,604 million to ¥20,713 million.
  9. FY2023-Q3WorsenedAnnual report

    「Other comprehensive income 5,574 (28,868) Valuation difference on available-for-sale securities 5,282 (29,377) Comprehensive income for the quarter 8,847 (25,664)」

    The valuation difference on available-for-sale securities changed from a gain of ¥5,282 million in the same period of the previous year to a loss of ¥29,377 million, while comprehensive income for the quarter also changed from a gain of ¥8,847 million to a loss of ¥25,664 million.
  10. FY2023-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities 4,000 (25,034) Comprehensive income for the interim period 5,836 (21,190)」

    The valuation difference on available-for-sale securities changed from a gain of ¥4,000 million in the same period of the previous year to a loss of ¥25,034 million, while comprehensive income for the interim period also changed from a gain of ¥5,836 million to a loss of ¥21,190 million.
  11. FY2023-Q1WorsenedAnnual report

    「Valuation difference on available-for-sale securities 3,657 (16,898) Comprehensive income for the quarter 4,222 (15,382)」

    The valuation difference on available-for-sale securities changed from a gain of ¥3,657 million in the same period of the previous year to a loss of ¥16,898 million, while comprehensive income for the quarter also changed from a gain of ¥4,222 million to a loss of ¥15,382 million.
  12. FY2022WorsenedAnnual report

    「Valuation difference on available-for-sale securities: 8,202, (8,753); comprehensive income: 15,056, (4,604)」

    The valuation difference on available-for-sale securities changed from a gain of ¥8,202 million to a loss of ¥8,753 million, while comprehensive income also changed from a gain of ¥15,056 million to a loss of ¥4,604 million.
  13. FY2022-Q3WorsenedAnnual report

    「Other comprehensive income 11,662 5,574 Valuation difference on available-for-sale securities 9,800 5,282 Deferred gains or losses on hedges 1,486 311 Remeasurements of defined benefit plans 375 (19) Comprehensive income for the quarter 13,855 8,847」

    Other comprehensive income decreased from ¥11,662 million in the same period of the previous year to ¥5,574 million, while the valuation difference on available-for-sale securities decreased from ¥9,800 million to ¥5,282 million. Comprehensive income for the quarter also decreased from ¥13,855 million to ¥8,847 million, but remained positive in the current period.
  14. FY2021MitigatedAnnual report

    「Valuation difference on available-for-sale securities: (2,274), 8,202; comprehensive income: 464, 15,056」

    The valuation difference on available-for-sale securities improved from a loss of ¥2,274 million in the previous fiscal year to a gain of ¥8,202 million, while comprehensive income improved from ¥464 million to ¥15,056 million.
  15. FY2021-Q3MitigatedAnnual report

    「Other comprehensive income 3,070 11,662 Valuation difference on available-for-sale securities 2,243 9,800 Comprehensive income for the quarter 6,516 13,855」

    Other comprehensive income increased from ¥3,070 million in the same period of the previous year to ¥11,662 million, while the valuation difference on available-for-sale securities increased from ¥2,243 million to ¥9,800 million. Comprehensive income for the quarter also increased from ¥6,516 million to ¥13,855 million.
  16. FY2021-Q2MitigatedAnnual report

    「Other comprehensive income: 1,877, 6,485; valuation difference on available-for-sale securities: 1,766, 5,210; comprehensive income for the interim period: 3,929, 7,386」

    The valuation difference on available-for-sale securities increased from ¥1,766 million in the same period of the previous year to ¥5,210 million, while comprehensive income for the interim period also increased from ¥3,929 million to ¥7,386 million. The valuation difference and comprehensive income improved from the same period of the previous year.
  17. FY2021-Q1MitigatedAnnual report

    「Other comprehensive income 284 4,627 Valuation difference on available-for-sale securities 546 3,583 Deferred gains or losses on hedges (299) 919 Remeasurements of defined benefit plans 37 125 Comprehensive income for the quarter 1,294 5,310」

    The valuation difference on available-for-sale securities increased from ¥546 million in the same period of the previous year to ¥3,583 million, while comprehensive income for the quarter also increased from ¥1,294 million to ¥5,310 million.
  18. FY2020WorsenedAnnual report

    「Other comprehensive income: (3,563), (10,539); valuation difference on available-for-sale securities: (2,274), (9,514); comprehensive income: 464, (7,997)」

    The loss on the valuation difference on available-for-sale securities widened from ¥2,274 million to ¥9,514 million, and comprehensive income also changed from a gain of ¥464 million to a loss of ¥7,997 million.
  19. FY2020-Q3MitigatedAnnual report

    「Other comprehensive income: (6,673), 3,070; valuation difference on available-for-sale securities: (6,407), 2,243; comprehensive income: (3,821), 6,516」

    Other comprehensive income and the valuation difference on available-for-sale securities turned from losses in the same period of the previous year to gains, while comprehensive income for the quarter also changed from a loss of ¥3,821 million to a gain of ¥6,516 million.
  20. FY2020-Q2MitigatedAnnual report

    「Other comprehensive income △170 1,877, Valuation difference on other securities △442 1,766, Interim comprehensive income 2,246 3,929」

    Other comprehensive income and valuation difference on other securities both changed from losses in the same period of the previous year to income, while interim comprehensive income increased from ¥2,246 million to ¥3,929 million.
  21. FY2020-Q1MitigatedAnnual report

    「Other comprehensive income △210 284 Valuation difference on other securities △182 546 Quarterly comprehensive income 1,323 1,294」

    Other comprehensive income changed from a loss of ¥210 million in the same period of the previous year to income of ¥284 million, while valuation difference on other securities also changed from a loss of ¥182 million to income of ¥546 million. Quarterly comprehensive income remained positive at ¥1,294 million.
  22. FY2019Full-year comprehensive income remained positive, while other comprehensive income was negativeAnnual report

    「Other comprehensive income 89 △3,563, Valuation difference on other securities △170 △2,274, Comprehensive income 5,077 464」

    Other comprehensive income was a loss of ¥3,563 million, and valuation difference on other securities also decreased by ¥2,274 million. Meanwhile, full-year comprehensive income remained positive at ¥464 million.
  23. FY2019-Q3First statedAnnual report

    「Other comprehensive income: 3,715; △6,673. Valuation differences on other securities: 3,404; △6,407. Quarterly comprehensive income: 8,155; △3,821.」

    Quarterly comprehensive income declined from ¥8.155 billion in the year-earlier period to a loss of ¥3.821 billion in the first nine months of the current period. Valuation differences on other securities also shifted from a ¥3.404 billion gain to a ¥6.407 billion loss.
Moved together

"Curbing reinvestment in securities to prioritize loan growth" moved the same way as this thread, in the same document, in 14 of its 23 moves.

1413121198★123456
  1. ★This thread
  2. 1Curbing reinvestment in securities to prioritize loan growth14×
  3. 2Expanding lending to residential mortgage borrowers, local companies, and local governments13×
  4. 3Market Risk from Fluctuations in Interest Rates, Securities Prices and Foreign Exchange Rates12×
  5. 4Risk of Deterioration in Credit Counterparties and an Increase in Non-Performing Loans11×
  6. 5Leasing Business Segment Turns Loss-Making9×
  7. 6Increase in Other Operating Expenses Due to Expenses for Financial Derivatives, etc.8×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for The Yamagata Bank yet. It last moved in the Earnings of 2026-08-03: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Quarterly Comprehensive Income Deficit Due to a Decrease in Valuation Differences on Other Securities | The Yamagata Bank,Ltd. (8344) | Komori